RXRX - These 3 Stocks Are the Future of Biotechnology
The biotech industry is heavily regulated by the federal government and its science watchdog, the Food and Drug Administration (FDA). As a consequence, biotech investors often evaluate a possible investment by looking at the company's pipeline of future assets. Research and development is a key factor in this sector.
So what biotech companies have the most exciting future prospects? Three Fool.com healthcare contributors like Vertex Pharmaceuticals (NASDAQ: VRTX) , Repligen (NASDAQ: RGEN) , and Recursion Pharmaceuticals (NASDAQ: RXRX) . Here's why they believe these three stocks are the future of biotechnology.
George Budwell (Vertex Pharmaceuticals): Vertex Pharmaceuticals has become a cash-printing machine recently thanks to its groundbreaking cystic fibrosis treatments like Trikafta. This single drug generated a whopping $5.7 billion in sales in 2021.
For further details see:
These 3 Stocks Are the Future of Biotechnology